发明名称 18232, a novel dual specificity phosphatase and uses therefor
摘要 The invention provides isolated nucleic acids molecules, designated 18232 nucleic acid molecules, which encode novel dual specificity phosphatase family members. The invention also provides antisense nucleic acid molecules, recombinant expression vectors containing 18232 nucleic acid molecules, host cells into which the expression vectors have been introduced, and nonhuman transgenic animals in which a 18232 gene has been introduced or disrupted. The invention still further provides isolated 18232 proteins, fusion proteins, antigenic peptides and anti-18232 antibodies. Diagnostic methods utilizing compositions of the invention are also provided. The invention also provides methods of modulating the differentiation and proliferation of hematopoietic cells (e.g., erythroid cells) utilizing the compositions of the invention. Accordingly, methods of treating, preventing and/or diagnosing erythroid-associated disorders such as anemias, leukemias, and erythrocytosis are disclosed.
申请公布号 US6420153(B1) 申请公布日期 2002.07.16
申请号 US20000704139 申请日期 2000.11.01
申请人 MILLENNIUM PHARMACEUTICALS, INC. 发明人 MEYERS RACHEL A.;WEICH NADINE
分类号 A61P7/00;C12N9/16;C12N15/55;(IPC1-7):C12N9/16;C12N1/20;C12N5/00;C07H21/02;C07H21/04 主分类号 A61P7/00
代理机构 代理人
主权项
地址